Is Sun Pharmaceutical Industries Limited FDA approved?

Sun Pharmaceutical Industries Limited holds 13 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Sun Pharmaceutical Industries Limited's drugs manufactured?

At registered sites in India, the United States. The FDA register lists Ahilyanagar; Ankleshwar; Bharuch; Chengalpattu; Dadra; Gurugram, and 6 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, repackaging.

What drugs does Sun Pharmaceutical Industries Limited make?

918 products are listed under Sun Pharmaceutical Industries Limited in the openFDA NDC Directory, most often as powder; tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Are any Sun Pharmaceutical Industries Limited products in shortage?

21 presentations are currently listed in the FDA drug shortage database under Sun Pharmaceutical Industries Limited, covering Lisdexamfetamine Dimesylate Capsule, Lisdexamfetamine Dimesylate Tablet, Chewable, Methylphenidate Hydrochloride Tablet, Extended Release and 1 other drug.

Sun Pharmaceutical Industries Limited

Data as of 28 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 13
Active NDC listings: 918
Labeller names: 8
Live patents: 110
Exclusivities: 2
Shortage listings: 24
Countries: 2
Base: India

Authorisation

Registered operations

Analytical testing13Active ingredient (API) manufacture5Labelling1Finished drug manufacture6Packaging2Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Sun Pharmaceutical Industries Limited	A-7 & A-8, MIDC Industrial Area, Ahilyanagar, Maharashtra 414111, India (IND)	Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture	3003227153862278942
Sun Pharmaceutical Industries Limited	Plot No. 4708, GIDC Industrial Estate, Ankleshwar, Gujarat 393002, India (IND)	Analytical testing, Active ingredient (API) manufacture	3012032037915854723
Sun Pharmaceutical Industries Limited	Plot No 24/2, 25, Phase IV, GIDC, Panoli, Bharuch, Gujarat 394116, India (IND)	Analytical testing, Active ingredient (API) manufacture	3003952717918591058
Sun Pharmaceutical Industries Limited	Plot No. Z-15, Dahej SEZ-I Industrial Area, Tal. Vagra, Bharuch, Gujarat 392130, India (IND)	Analytical testing, Active ingredient (API) manufacture	3010027135860038081
Sun Pharmaceutical Industries Limited	Sathammai Village, Karunkuzhi Post, Madhuranthagam Taluk, Chengalpattu, Tamil Nadu 603303, India (IND)	Analytical testing, Active ingredient (API) manufacture	3007627683915044075
Sun Pharmaceutical Industries Limited	Survey No. 1012, Dadra, Union Territory of Dadra and Nagar Haveli and Daman and Diu 396193, India (IND)	Analytical testing, Finished drug manufacture	3004561553650445203
Sun Pharmaceutical Industries Limited	Sarhaul, Sector-18, Gurugram, Haryana 122015, India (IND)	Analytical testing	3002871444650654804
Sun Pharmaceutical Industries Limited	Halol-Baroda Highway, Halol, Gujarat 389350, India (IND)	Analytical testing, Finished drug manufacture	3002809586725959238
Sun Pharmaceutical Industries Limited	Plot No. A-41, Industrial Area Phase-VIII A, S.A.S. Nagar, Mohali, Punjab 160071, India (IND)	Analytical testing, Finished drug manufacture	3002807979650456002
Sun Pharmaceutical Industries Limited	Hakeem Abdul Hameed Centenary Hospital, (2nd Floor) Jamia Hamdard (Hamdard University) Hamdard Nagar, New Delhi, Delhi 110062, India (IND)	Analytical testing	3003892973650645877
Sun Pharmaceutical Industries Limited	F P No. 27, Part Survey No. 27, C.S. No. 1050, TPS No. 24, Village Tandalja, Vadodara, Gujarat 390012, India (IND)	Analytical testing	3004520113918459363
Sun Pharmaceutical Industries, Inc.	29 Dunham Rd, Billerica, Massachusetts (MA) 01821, United States (USA)	Analytical testing, Labelling, Finished drug manufacture, Packaging	3009395771037074409
Ohm Laboratories Inc.Registrant: Sun Pharmaceutical Industries, Inc.	1385 Livingston Ave, North Brunswick, New Jersey (NJ) 08902, United States (USA)	Analytical testing, Finished drug manufacture, Packaging, Repackaging	3004132058051565745

Alert

Drug shortage listings

Drug	Presentation	Status	Availability	Posted / updated
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88)	Current	Limited Availability	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88)	Current	Limited Availability	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88)	Current	Limited Availability	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88)	Current	Limited Availability	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88)	Current	Limited Availability	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88)	Current	Limited Availability	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-047-88)	Current	Limited Availability	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate Tablet, ChewablePsychiatry	Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88)	Current	Available	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate Tablet, ChewablePsychiatry	Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88)	Current	Available	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate Tablet, ChewablePsychiatry	Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88)	Current	Available	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate Tablet, ChewablePsychiatry	Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88)	Current	Available	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate Tablet, ChewablePsychiatry	Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88)	Current	Available	14 Jul 202318 Sept 2026
Lisdexamfetamine Dimesylate Tablet, ChewablePsychiatry	Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88)	Current	Available	14 Jul 202318 Sept 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)	Current	Unavailable	26 Jul 202318 Sept 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)	Current	Unavailable	26 Jul 202318 Sept 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)	Current	Unavailable	26 Jul 202318 Sept 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88)	Current	Unavailable	26 Jul 202318 Sept 2026
Technetium TC-99M Pyrophosphate Kit InjectionMedical Imaging	CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2)	Current	Unavailable	27 Dec 202318 Sept 2026
Technetium TC-99M Pyrophosphate Kit InjectionMedical Imaging	CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1)	Current	Unavailable	27 Dec 202318 Sept 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-048-88)	Current	Limited Availability	14 Jul 202327 Aug 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-048-88)	Current	Limited Availability	14 Jul 202327 Aug 2026
Pindolol TabletCardiovascular	Pindolol, Tablet, 10 mg (NDC 57664-656-88)	To Be Discontinued	-	30 Jan 202630 Jan 2026
Pindolol TabletCardiovascular	Pindolol, Tablet, 5 mg (NDC 57664-655-88)	To Be Discontinued	-	30 Jan 202630 Jan 2026
Vecuronium Bromide InjectionAnesthesia	Vecuronium Bromide, Injection, 20 mg (NDC 47335-932-44)	To Be Discontinued	-	8 Sept 20258 Sept 2025

Catalogue

Drug listings by form and route

918

918 active NDC listings: 705 human prescription drug, 154 bulk ingredient, 58 human otc drug, 1 drug for further processing. By marketing category: ANDA 666, BULK INGREDIENT 154, NDA 56, OTC MONOGRAPH DRUG 18, NDA AUTHORIZED GENERIC 13.

Dosage form	NDCs
powder	154
tablet	138
tablet, film coated	113
capsule	97
cream	66
capsule, extended release	40
solution	39
tablet, extended release	33
ointment	24
tablet, film coated, extended release	24
injection, solution	23
gel	20
suspension	18
injection, powder, lyophilized, for solution	11
tablet, orally disintegrating	10

Route	NDCs
oral	523
topical	145
intravenous	40
respiratory (inhalation)	11
intramuscular	9
ophthalmic	9
subcutaneous	9
vaginal	8
sublingual	4
rectal	3
auricular (otic)	2
dental	2
nasal	2
intraocular	1

Labeller name on the listing	NDCs
sun pharmaceutical industries, inc.	707
sun pharmaceutical industries, inc.	166
sun pharmaceutical industries inc.	15
sun pharmaceutical industries limited	12
sun pharmaceutical industries, inc	9
sun pharmaceutical industries inc	5
sun pharmaceutical industries inc	3
sun pharmaceuticals industries, inc.	1

Exclusivity

Patents and exclusivities

110

Patent	Product	Covers	Expiry
8143240	WINLEVIclascoterone	use	Jan 2027
11938141	WINLEVIclascoterone	product	Jul 2028
12337002	WINLEVIclascoterone	product	Jul 2028
9486458	WINLEVIclascoterone	use	Jul 2028
10159682	WINLEVIclascoterone	use	Aug 2028
8277780	TOPICORTdesoximetasone	product	Sept 2028
7799331	FLO-PREDprednisolone acetate	product	Oct 2028
9539262	XELPROSlatanoprost	use	Oct 2028
11207332	WINLEVIclascoterone	product	Nov 2028
9433628	WINLEVIclascoterone	product	Feb 2029
RE50218	BROMSITEbromfenac sodium	product	Mar 2029
8178563	ODOMZOsonidegib phosphate	substance	Jul 2029
9629852	XELPROSlatanoprost	product	Sept 2029
8063043	ODOMZOsonidegib phosphate	substance, product	Sept 2029
8785427	WINLEVIclascoterone	product	Jul 2030
9241948	INFUGEMgemcitabine hydrochloride	product	Jul 2033
10441630	CEQUAcyclosporine	product	Aug 2033
8980839	CEQUAcyclosporine	product	Aug 2033
9937225	CEQUAcyclosporine	product	Aug 2033
9889144	YONSAabiraterone acetate	product	Mar 2034
10292990	YONSAabiraterone acetate	use	May 2034
9962336	RIOMET ERmetformin hydrochloride	product	May 2035
9750711	ABSORICA LDisotretinoin	product	May 2035
9504655	KAPSPARGO SPRINKLEmetoprolol succinate	product	Jul 2035
9700530	KAPSPARGO SPRINKLEmetoprolol succinate	product	Jul 2035
9700535	ABSORICA LDisotretinoin	product	Aug 2035
10413543	EZALLOR SPRINKLErosuvastatin calcium	product	Feb 2036
10266523	ODOMZOsonidegib phosphate	substance, product	Mar 2036
10172802	ORTIKOSbudesonide	use	Sept 2036
9707182	ORTIKOSbudesonide	product	Sept 2036
11179574	LEVULANaminolevulinic acid hydrochloride	use	Oct 2036
11697028	LEVULANaminolevulinic acid hydrochloride	use	Oct 2036
12290700	LEVULANaminolevulinic acid hydrochloride	use	Oct 2036
11446512	LEVULANaminolevulinic acid hydrochloride	use	Jan 2037
10918694	CEQUAcyclosporine	product	Feb 2037
11951153	CEQUAcyclosporine	use	Feb 2037
10413525	DRIZALMA SPRINKLEduloxetine hydrochloride	product	Apr 2037
10959982	DRIZALMA SPRINKLEduloxetine hydrochloride	product	Apr 2037
11202772	DRIZALMA SPRINKLEduloxetine hydrochloride	product	Apr 2037
12171742	DRIZALMA SPRINKLEduloxetine hydrochloride	product	Apr 2037
9839626	DRIZALMA SPRINKLEduloxetine hydrochloride	product	Apr 2037
10561659	LEQSELVIdeuruxolitinib phosphate	use	May 2037
12076323	LEQSELVIdeuruxolitinib phosphate	use	May 2037
10357567	LEVULANaminolevulinic acid hydrochloride	use	Jan 2038
11077192	LEVULANaminolevulinic acid hydrochloride	use	Jan 2038
11135293	LEVULANaminolevulinic acid hydrochloride	use	Jan 2038
11571478	LEVULANaminolevulinic acid hydrochloride	use	Jan 2038
11690914	LEVULANaminolevulinic acid hydrochloride	use	Jan 2038
12296011	LEVULANaminolevulinic acid hydrochloride	use	Jan 2038
10898444	ASPRUZYO SPRINKLEranolazine	product	Jan 2038
11510878	ASPRUZYO SPRINKLEranolazine	product	Jan 2038
12161761	ASPRUZYO SPRINKLEranolazine	product	Jan 2038
10342850	BYNFEZIA PENoctreotide acetate	product	May 2038
11052196	BYNFEZIA PENoctreotide acetate	use	Nov 2040
11246991	BYNFEZIA PENoctreotide acetate	use	Nov 2040
11534553	BYNFEZIA PENoctreotide acetate	use	Nov 2040
11919907	LEQSELVIdeuruxolitinib phosphate	product	May 2041
12350475	BYNFEZIA PENoctreotide acetate	use	Dec 2041
11857683	SEZABYphenobarbital sodium	product	Apr 2042
12636254	SEZABYphenobarbital sodium	product	Apr 2042

Product	Exclusivity	Until
LEQSELVIDEURUXOLITINIB PHOSPHATE	NCE New chemical entity	Jul 2029
SEZABYPHENOBARBITAL SODIUM	ODE-414 Orphan drug	Nov 2029

Catalogue

Marketed products

918

Showing 150 of 918.

Brand	Generic name	Form / route	NDC
ADAPALENE and BENZOYL PEROXIDE	ADAPALENE and BENZOYL PEROXIDE	gel, topical	51672-1364ANDA
ASPRUZYO SPRINKLE	Ranolazine	granule, oral	47335-625NDA
-	Abiraterone Acetate	powder	62756-199BULK INGREDIENT
Absorica	isotretinoin	capsule, oral	10631-115NDA
Absorica	isotretinoin	capsule, oral	10631-116NDA
Absorica	isotretinoin	capsule, oral	10631-117NDA
Absorica	isotretinoin	capsule, oral	10631-118NDA
Absorica	isotretinoin	capsule, oral	10631-133NDA
Absorica	isotretinoin	capsule, oral	10631-134NDA
Absorica LD	isotretinoin	capsule, oral	10631-002NDA
Absorica LD	isotretinoin	capsule, oral	10631-003NDA
Absorica LD	isotretinoin	capsule, oral	10631-005NDA
Absorica LD	isotretinoin	capsule, oral	10631-007NDA
Acetaminophen 250 mg and Ibuprofen 125 mg	Acetaminophen 250 mg and Ibuprofen 125 mg Tablets	tablet, oral	51672-4258ANDA
-	Acitretin	powder	62756-269BULK INGREDIENT
Acyclovir	Acyclovir	ointment, topical	51672-1360ANDA
Acyclovir	Acyclovir	cream, topical	51672-1361ANDA
Adapalene	Adapalene	gel, topical	51672-1377ANDA
Adapalene	Adapalene	gel, topical	51672-2150ANDA
Adapalene and Benzoyl Peroxide	ADAPALENE and BENZOYL PEROXIDE	gel, topical	51672-1384ANDA
-	Afatinib Dimaleate	powder	62756-050BULK INGREDIENT
AfterPlan	levonorgestrel	tablet, oral	62756-723ANDA
Albuterol Sulfate	albuterol sulfate	solution, respiratory (inhalation)	47335-703ANDA
Alclometasone Dipropionate	Alclometasone dipropionate	ointment, topical	51672-1316ANDA
Alclometasone dipropionate	Alclometasone dipropionate	cream, topical	51672-1306ANDA
-	Alectinib Hydrochloride	powder	62756-704BULK INGREDIENT
-	Alendronate Sodium	powder	62756-112BULK INGREDIENT
Alfuzosin Hydrochloride	Alfuzosin Hydrochloride	tablet, extended release, oral	47335-956ANDA
Allopurinol	Allopurinol	tablet, oral	53489-156ANDA
Allopurinol	Allopurinol	tablet, oral	53489-157ANDA
Amcinonide	Amcinonide	ointment, topical	51672-4060ANDA
-	Amifostine	powder	62756-127BULK INGREDIENT
Amiodarone Hydrochloride	Amiodarone Hydrochloride	tablet, oral	51672-4025ANDA
Amiodarone Hydrochloride	Amiodarone Hydrochloride	tablet, oral	51672-4055ANDA
Amiodarone Hydrochloride	Amiodarone Hydrochloride	tablet, oral	51672-4056ANDA
Amiodarone Hydrochloride	Amiodarone Hydrochloride	tablet, oral	51672-4057ANDA
Amitriptyline Hydrochloride	Amitriptyline Hydrochloride	tablet, film coated, oral	57664-687ANDA
Amitriptyline Hydrochloride	Amitriptyline Hydrochloride	tablet, film coated, oral	57664-688ANDA
Amitriptyline Hydrochloride	Amitriptyline Hydrochloride	tablet, film coated, oral	57664-689ANDA
Amitriptyline Hydrochloride	Amitriptyline Hydrochloride	tablet, film coated, oral	57664-690ANDA
Amitriptyline Hydrochloride	Amitriptyline Hydrochloride	tablet, film coated, oral	57664-691ANDA
Amitriptyline Hydrochloride	Amitriptyline Hydrochloride	tablet, film coated, oral	57664-692ANDA
Ammonium Lactate	Ammonium Lactate	lotion, topical	51672-1300ANDA
Ammonium Lactate	Ammonium Lactate	cream, topical	51672-1301ANDA
Amphotericin B	Amphotericin B	injectable, liposomal, intravenous	62756-233ANDA
Amphotericin B	Amphotericin B	injectable, liposomal, intravenous	62756-954ANDA
-	Apremilast	powder	62756-690BULK INGREDIENT
Arformoterol Tartrate	Arformoterol Tartrate	solution, respiratory (inhalation)	62756-277ANDA
-	Aripiprazole	powder	62756-919BULK INGREDIENT
-	Asenapine Maleate	powder	62756-784BULK INGREDIENT
Athletes Foot	Butenafine Hydrochloride	cream, topical	51672-2100ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	63304-829ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	63304-830ANDA
-	Atorvastatin Calcium Trihydrate	powder	62756-034BULK INGREDIENT
-	Azacitidine	powder	62756-151BULK INGREDIENT
Azelaic Acid	Azelaic Acid	gel, topical	51672-1389ANDA
Azelastine Hydrochloride	Azelastine Hydrochloride	spray, metered, nasal	47335-779ANDA
Azelastine Hydrochloride	Azelastine Hydrochloride	solution/ drops, intraocular	47335-938ANDA
Azithromycin	Azithromycin	injection, powder, lyophilized, for solution, intravenous	62756-512ANDA
Azithromycin monohydrate	Azithromycin monohydrate	injection, powder, lyophilized, for solution, intravenous	70095-025ANDA
BETAMETHASONE VALERATE	Betamethasone Valerate	cream, topical	51672-1269ANDA
BISOPROLOL FUMARATE	BISOPROLOL FUMARATE	tablet, film coated, oral	70095-019ANDA
BISOPROLOL FUMARATE	BISOPROLOL FUMARATE	tablet, film coated, oral	70095-020ANDA
BROMSITE 0.075%	bromfenac	solution/ drops, ophthalmic	49708-754NDA
BYNFEZIA Pen	octreotide acetate	injection, subcutaneous	62756-452NDA
Bacitracin Zinc	Bacitracin Zinc	ointment, topical	51672-2075OTC MONOGRAPH DRUG
Bactrim	sulfamethoxazole and Trimethoprim	tablet, oral	49708-145NDA
Bactrim DS	sulfamethoxazole and Trimethoprim	tablet, oral	49708-146NDA
-	Bendamustine hydrochloride	powder	62756-009BULK INGREDIENT
Betamethasone Dipropionate	Betamethasone Dipropionate	cream, topical	51672-1274ANDA
Betamethasone Dipropionate	Betamethasone Dipropionate	gel, topical	51672-1309ANDA
Betamethasone Dipropionate	Betamethasone Dipropionate	cream, augmented, topical	51672-1310ANDA
Betamethasone Dipropionate	Betamethasone Dipropionate	lotion, augmented, topical	51672-1340ANDA
Betamethasone Valerate	Betamethasone Valerate	aerosol, foam, topical	51672-4188ANDA
Betamethasone dipropionate	Betamethasone dipropionate	spray, topical	51672-1390ANDA
-	Bicalutamide	powder	62756-942BULK INGREDIENT
-	Bivalirudin	powder	62756-051BULK INGREDIENT
-	Bortezomib	powder	62756-982BULK INGREDIENT
Bosentan	Bosentan	tablet, film coated, oral	47335-038ANDA
Bosentan	Bosentan	tablet, film coated, oral	47335-039ANDA
-	Bosentan Monohydrate	powder	62756-048BULK INGREDIENT
-	Bosutinib	powder	62756-721BULK INGREDIENT
Budesonide	Budesonide	suspension, respiratory (inhalation)	47335-631ANDA
Budesonide	Budesonide	suspension, respiratory (inhalation)	47335-632ANDA
Budesonide	Budesonide	suspension, respiratory (inhalation)	47335-633ANDA
-	Budesonide	powder	62756-089BULK INGREDIENT
Bumetanide	Bumetanide	tablet, oral	51672-4223ANDA
Bumetanide	Bumetanide	tablet, oral	51672-4224ANDA
Bumetanide	Bumetanide	tablet, oral	51672-4225ANDA
-	Buprenorphine	powder	62756-027BULK INGREDIENT
Buprenorphine	Buprenorphine	tablet, sublingual	62756-459ANDA
Buprenorphine	Buprenorphine	tablet, sublingual	62756-460ANDA
-	Buprenorphine Base	powder	62756-189BULK INGREDIENT
-	Buprenorphine Hydrochloride	powder	62756-316BULK INGREDIENT
Buprenorphine and Naloxone	Buprenorphine and Naloxone	tablet, sublingual	62756-969ANDA
Buprenorphine and Naloxone	Buprenorphine and Naloxone	tablet, sublingual	62756-970ANDA
Bupropion Hydrochloride	Bupropion Hydrochloride	tablet, extended release, oral	47335-954ANDA
-	Bupropion Hydrochloride	powder	62756-125BULK INGREDIENT
Bupropion hydrochloride	Bupropion hydrochloride	tablet, film coated, extended release, oral	47335-736ANDA
Bupropion hydrochloride	Bupropion hydrochloride	tablet, film coated, extended release, oral	47335-737ANDA
Bupropion hydrochloride	Bupropion hydrochloride	tablet, film coated, extended release, oral	47335-738ANDA
Butalbital, Acetaminophen and Caffeine	butalbital, acetaminophen, and caffeine	capsule, oral	51672-4222ANDA
CARBIDOPA AND LEVODOPA	CARBIDOPA AND LEVODOPA	tablet, orally disintegrating, oral	47335-186ANDA
CARBIDOPA AND LEVODOPA	CARBIDOPA AND LEVODOPA	tablet, orally disintegrating, oral	47335-187ANDA
CARBIDOPA AND LEVODOPA	CARBIDOPA AND LEVODOPA	tablet, orally disintegrating, oral	47335-188ANDA
CARBIDOPA AND LEVODOPA	CARBIDOPA AND LEVODOPA	tablet, extended release, oral	62756-457ANDA
CARBIDOPA AND LEVODOPA	CARBIDOPA AND LEVODOPA	tablet, extended release, oral	62756-461ANDA
CARBIDOPA AND LEVODOPA	CARBIDOPA AND LEVODOPA	tablet, oral	62756-517ANDA
CARBIDOPA AND LEVODOPA	CARBIDOPA AND LEVODOPA	tablet, oral	62756-518ANDA
CARBIDOPA AND LEVODOPA	CARBIDOPA AND LEVODOPA	tablet, oral	62756-985ANDA
CEQUA	cyclosporine	solution/ drops, ophthalmic, topical	47335-506NDA
CEQUA	cyclosporine	solution/ drops, ophthalmic, topical	47335-507NDA
CHLOROTHIAZIDE SODIUM	CHLOROTHIAZIDE SODIUM	injection, powder, lyophilized, for solution, intravenous	47335-330ANDA
CLOMIPRAMINE HYDROCHLORIDE	Clomipramine Hydrochloride	capsule, oral	51672-4011ANDA
CLOMIPRAMINE HYDROCHLORIDE	Clomipramine Hydrochloride	capsule, oral	51672-4012ANDA
CLOMIPRAMINE HYDROCHLORIDE	Clomipramine Hydrochloride	capsule, oral	51672-4013ANDA
Caffeine Citrate	Caffeine Citrate	injection, intravenous	47335-289ANDA
Caffeine Citrate	Caffeine Citrate	solution, oral	47335-290ANDA
Calcipotriene	Calcipotriene	ointment, topical	51672-4154ANDA
Calcipotriene and Betamethasone Dipropionate	Calcipotriene and Betamethasone Dipropionate	suspension, topical	51672-1402ANDA
Calcitrene	Calcipotriene	ointment, topical	51672-5278ANDA
Calcitriol	Calcitriol	capsule, liquid filled, oral	62756-967ANDA
Calcitriol	Calcitriol	capsule, liquid filled, oral	62756-968ANDA
-	Canagliflozin crystalline	powder	54907-0138BULK INGREDIENT
-	Capecitabine	powder	62756-088BULK INGREDIENT
Capecitabine	Capecitabine	tablet, film coated, oral	62756-238ANDA
Capecitabine	Capecitabine	tablet, film coated, oral	62756-239ANDA
Carbamazepine	Carbamazepine	tablet, oral	51672-4005ANDA
Carbamazepine	Carbamazepine	tablet, chewable, oral	51672-4041ANDA
Carbamazepine	Carbamazepine	suspension, oral	51672-4047ANDA
Carbamazepine	Carbamazepine	tablet, chewable, oral	51672-4050ANDA
Carbamazepine	Carbamazepine	tablet, extended release, oral	51672-4123ANDA
Carbamazepine	Carbamazepine	tablet, extended release, oral	51672-4124ANDA
Carbamazepine	Carbamazepine	tablet, extended release, oral	51672-4125ANDA
-	Carboplatin	powder	62756-121BULK INGREDIENT
-	Cariprazine Hydrochloride	powder	54907-0141BULK INGREDIENT
-	Carisoprodol	powder	62756-808BULK INGREDIENT
-	Carvedilol	powder	62756-122BULK INGREDIENT
Carvedilol Phosphate	Carvedilol Phosphate	capsule, extended release, oral	57664-663ANDA
Carvedilol Phosphate	Carvedilol Phosphate	capsule, extended release, oral	57664-664ANDA
Carvedilol Phosphate	Carvedilol Phosphate	capsule, extended release, oral	57664-665ANDA
Carvedilol Phosphate	Carvedilol Phosphate	capsule, extended release, oral	57664-666ANDA
-	Cetirizine Dihydrochloride	powder	62756-226BULK INGREDIENT
Cetirizine Hydrochloride	Cetirizine Hydrochloride	solution, oral	51672-2106ANDA
Cetirizine Hydrochloride	Cetirizine Hydrochloride	solution, oral	51672-4070ANDA
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	tablet, film coated, extended release, oral	62756-915ANDA
Cevimeline	Cevimeline	capsule, oral	63304-479NDA
Childrens Cetirizine Hydrochloride	Cetirizine Hydrochloride	solution, oral	51672-2147ANDA
Childrens Cetirizine Hydrochloride Sugar Free Grape	Cetirizine Hydrochloride	solution, oral	51672-2102ANDA
Childrens Fexofenadine Hydrochloride Allergy	FEXOFENADINE HYDROCHLORIDE	suspension, oral	51672-2141ANDA

Neighbours

Registered in the same town

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITEDHalol, IND; Vadodara, IND · 5 sites
Alembic Pharmaceuticals LimitedVADODARA, IND; Vadodara, IND · 4 sites
Zydus Lifesciences LimitedAnkleshwar, IND; Vadodara, IND · 3 sites
Unique Pharmaceutical Laboratories (A Div. of JB Chemicals & Pharmaceuticals Ltd)Bharuch, IND · 3 sites
FARMSON BASIC DRUGS PRIVATE LIMITEDBharuch, IND; Vadodara, IND · 3 sites
Lupin LimitedAnkleshwar, IND; Vadodara, IND · 2 sites
Glenmark Pharmaceuticals Inc., USAAnkleshwar, IND; Bharuch, IND · 2 sites
Intas Pharmaceuticals LimitedAnkleshwar, IND; Bharuch, IND · 2 sites
Alkem Laboratories LimitedBharuch, IND · 2 sites
Cadila Pharmaceuticals LimitedAnkleshwar, IND · 2 sites
KLM Laboratories Private LimitedVadodara, IND · 2 sites
Meghmani LLPBHARUCH, IND; Bharuch, IND · 2 sites

Compare

Comparable companies in India

Zydus Lifesciences Limited12 sites · 717 NDC
Lupin Limited14 sites · 506 NDC
Amneal Pharmaceuticals of New York, LLC14 sites · 227 NDC
Dr. Reddy's Laboratories Limited15 sites · 683 NDC
Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
Biocon Biologics Limited9 sites · 176 NDC
Viyash Scientific Limited9 sites · 58 NDC
Granules Pharmaceuticals Inc.8 sites · 302 NDC
MSN Laboratories Private Limited,8 sites · 275 NDC
Hetero Labs Limited8 sites · 167 NDC

Enquiry

Common questions

Is Sun Pharmaceutical Industries Limited FDA approved?: Sun Pharmaceutical Industries Limited holds 13 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Sun Pharmaceutical Industries Limited's drugs manufactured?: At registered sites in India, the United States. The FDA register lists Ahilyanagar; Ankleshwar; Bharuch; Chengalpattu; Dadra; Gurugram, and 6 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, repackaging.
What drugs does Sun Pharmaceutical Industries Limited make?: 918 products are listed under Sun Pharmaceutical Industries Limited in the openFDA NDC Directory, most often as powder; tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Are any Sun Pharmaceutical Industries Limited products in shortage?: 21 presentations are currently listed in the FDA drug shortage database under Sun Pharmaceutical Industries Limited, covering Lisdexamfetamine Dimesylate Capsule, Lisdexamfetamine Dimesylate Tablet, Chewable, Methylphenidate Hydrochloride Tablet, Extended Release and 1 other drug.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.